Nanobiotechnology – TechConnect Briefs

The importance of R&D alliances to sustain a nano-biotechnology ecosystem

Wauters J., Flanders Investment and Trade - Consulate General of Belgium, US

The breakthroughs in nanoelectronics, nanotechnology and biotechnology are resulting in a growing convergence of nano with bio, as they both ‘work’ at the nanoscale. Think e.g. of nanotherapeutics, where nanoparticles, loaded with drugs, can be [...]

Nano-Biotechnology toward Diagnostic Industry: Obstacles and Opportunities

Esfandyarpour H., Stanford, US

Biosensing of infectious agents should be ideally real-time, multiplexed, sensitive and specific. While no single device thus far have demonstrated superiority with respect to all these qualities, many of the upcoming nanomaterial-based sensors described in [...]

Scalable Fabrication of Polymeric and Organic Nanomaterials using Particle Replication in Non-wetting Templates (PRINT) and Imprint Lithography

Maynor B.W., Denison G.M., Rolland J.P., DeSimone J.M., Liquidia Technologies, US

We have developed scalable, “top-down” nanofabrication methodologies for the fabrication of polymeric and organic nanostructures for nanobiotechnology and materials engineering. These techniques use novel perfluoropolyether (PFPE) elastomers that possess superior nanoimprinting properties, including error-free nanoscale [...]

Sensing and Plotting Single Molecule Binding Events with the Atomic Force Microscope

Johnson W.T., Molecular Imaging, US

SPM/AFM (scanning probe microscopy/atomic force microscopy) offers many unique advantages to the study of biological process at the nanometer scale. ASM/AFM allows scientists to visualize, probe, and analyze the structure of biological molecules in their [...]

Nanobiotechnology: Responsible Action on Issues in Society and Ethics

Bennett D.J., Schuurbiers D., European Federation of Biotechnology, NL

The overall aim of this initiative is both, firstly, to anticipate the societal and ethical issues likely to arise as nanobiotechnologies develop and, secondly, to use the lessons from the European GM debate to respond [...]